Funding Intelligence

IP : OQC Secures $260 Million in Latest Series C Funding Round

Funding Intelligence Staff · · 2 min read

IP : OQC secured $260 million in its latest Series C, adding another data point to the Healthcare & Life Sciences funding market.

Series C$260 millionHealthcare & Life Sciencesthe UK

IP : OQC Raises $260 million in Funding

IP : OQC is a the UK-based Digital Health company focused on expand quantum computing access globally.

Investors Behind the Funding

The round was backed by undisclosed investors. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

IP : OQC operates in Healthcare & Life Sciences. IP : OQC's Series C round shows investors are still backing digital health platforms with real scale narratives. At $260M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

expand quantum computing access globally

Looking Ahead

IP : OQC raises £260m in Europe's largest ever private quantum computing funding round

Source reference: original announcement/article.

View IP : OQC's full profile and funding history on Funding Intelligence →